Janux Therapeutics (NASDAQ:JANX) just reported results for the fourth quarter of 2023.
- Janux Therapeutics reported earnings per share of -25 cents. This was above the analyst estimate for EPS of -40 cents.
- The company reported revenue of $2.46 million.
- This was 228.13% better than the analyst estimate for revenue of $750,000.